208 related articles for article (PubMed ID: 7268339)
21. Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group.
Crump M; Tu D; Shepherd L; Levine M; Bramwell V; Pritchard K
J Clin Oncol; 2003 Aug; 21(16):3066-71. PubMed ID: 12915595
[TBL] [Abstract][Full Text] [Related]
22. [Adjuvant chemotherapy in breast cancer].
Senn HJ
Dtsch Med Wochenschr; 1981 Nov; 106(48):1626-30. PubMed ID: 7030686
[No Abstract] [Full Text] [Related]
23. A comparison of the outcomes of non-randomised chemotherapy regimens in node positive breast cancer.
Kuru B; Camlibel M; Dinc S; Gulcelik MA; Atalay C; Alagol H
J Exp Clin Cancer Res; 2005 Sep; 24(3):363-72. PubMed ID: 16270522
[TBL] [Abstract][Full Text] [Related]
24. A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma.
Bellon JR; Shulman LN; Come SE; Li X; Gelman RS; Silver BJ; Harris JR; Recht A
Cancer; 2004 Apr; 100(7):1358-64. PubMed ID: 15042668
[TBL] [Abstract][Full Text] [Related]
25. [The state of hormone and chemotherapy in breast neoplasms].
Brunner KW
Schweiz Med Wochenschr; 1978 Sep; 108(35):1338-50. PubMed ID: 210499
[TBL] [Abstract][Full Text] [Related]
26. Surgery and adjuvant chemotherapy in the treatment of operable breast cancer.
Rossi A; Valagussa P; Bonadonna G
Prog Clin Biol Res; 1977; 12():391-404. PubMed ID: 335401
[No Abstract] [Full Text] [Related]
27. Controversies in the treatment of cancer of the breast.
Swain SM; Lippman ME
Annu Rev Med; 1987; 38():287-94. PubMed ID: 3555297
[TBL] [Abstract][Full Text] [Related]
28. [Adjuvant chemotherapy in breast neoplasms. Clinical and immunologic results].
Melchert F; Kreienberg R; von Nathusius U
Fortschr Med; 1980 Feb; 98(8):281-6. PubMed ID: 7380377
[TBL] [Abstract][Full Text] [Related]
29. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
[TBL] [Abstract][Full Text] [Related]
30. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
[TBL] [Abstract][Full Text] [Related]
31. Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.
Fisher B; Jeong JH; Anderson S; Wolmark N
J Natl Cancer Inst; 2004 Dec; 96(24):1823-31. PubMed ID: 15601638
[TBL] [Abstract][Full Text] [Related]
32. [Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy].
Mouridsen HT; Palshof T; Brahm M; Rahbek I
Ugeskr Laeger; 1977 Oct; 139(44):2632-5. PubMed ID: 929742
[No Abstract] [Full Text] [Related]
33. [The results of 5 years of ancillary chemotherapy of carcinoma of the breast (author's transl)].
von Maillot K; Egger H; Gunselmann W
Geburtshilfe Frauenheilkd; 1981 Jul; 41(7):461-4. PubMed ID: 7021305
[TBL] [Abstract][Full Text] [Related]
34. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
Watanabe T; Sano M; Takashima S; Kitaya T; Tokuda Y; Yoshimoto M; Kohno N; Nakagami K; Iwata H; Shimozuma K; Sonoo H; Tsuda H; Sakamoto G; Ohashi Y
J Clin Oncol; 2009 Mar; 27(9):1368-74. PubMed ID: 19204202
[TBL] [Abstract][Full Text] [Related]
35. [Chemotherapy as an adjuvant treatment in breast cancer (author's transl)].
Firusian N; Hossfeld DK; John V
Rontgenblatter; 1978 Jul; 31(7):423-8. PubMed ID: 99800
[TBL] [Abstract][Full Text] [Related]
36. Cyclical combination chemotherapy in advanced breast cancer.
Edelstyn GA; Marcrae KD
Ann R Coll Surg Engl; 1974 Jun; 54(6):275-6. PubMed ID: 4833779
[No Abstract] [Full Text] [Related]
37. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: indirect comparison of dose and schedule in DBCG trials 77, 82, and 89.
Ejlertsen B; Mouridsen HT; Jensen MB
Acta Oncol; 2008; 47(4):662-71. PubMed ID: 18465334
[TBL] [Abstract][Full Text] [Related]
38. [Prospective randomized trial on the efficacy of adjuvant endocrine therapy for ER-positive breast cancer patients after radical mastectomy].
Jiang Z; Song S; Liu X
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):420-2. PubMed ID: 11810777
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant treatment of cancer. II. Breast carcinoma.
Viola MV; Nystrom JS
Conn Med; 1977 Jun; 41(6):333-5. PubMed ID: 872584
[No Abstract] [Full Text] [Related]
40. Breast cancer 1984: state of the art.
Sledge GW
Indiana Med; 1984 Dec; 77(12):935-9. PubMed ID: 6394645
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
